Patents
Patents for C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media (9,992)
08/2004
08/11/2004EP1445322A1 Packaging systems for human recombinant adenovirus to be used in gene therapy
08/11/2004EP1444362A2 High-throughput transcriptome and functional validation analysis
08/11/2004EP1444259A2 Adenylate cyclase with additional ion channel domain
08/11/2004EP1444254A2 Molecules for disease detection and treatment
08/11/2004EP0821728B1 Tie-2 ligands, methods of making and uses thereof
08/11/2004EP0749472B1 Extracorporeal cell culture and transplantation kits
08/11/2004CN1520516A T1R hetero-oligomeric taste receptors and cell lines that express said receptors and use thereof for identification of taste compounds
08/11/2004CN1161380C Method for purifying keratinocyte growth factors
08/05/2004WO2004065583A2 Gene expression markers for breast cancer prognosis
08/05/2004WO2004065582A2 Amplification of dna in a hairpin structure, and applications
08/05/2004WO2004065578A2 Microparticles comprising polynucleotide adsorbed on the surface of or entrapped within the microparticles
08/05/2004WO2004065570A2 Methods of metallizing nucleic acid molecules and methods of attaching nucleic acid molecules to conductive surfaces
08/05/2004WO2004065568A2 Rapid growing microorganisms for biotechnology applications
08/05/2004WO2004065565A2 Identification and use of informative sequences
08/05/2004WO2004065562A2 Endocan compositions and methods for the treatment of neoplasms
08/05/2004WO2004065559A2 Power conditioners and pseudo isolation for a two-wire processing network
08/05/2004WO2004065550A2 Nucleic acid amplification using non-standard bases
08/05/2004WO2004065547A2 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
08/05/2004WO2004065545A2 Diagnosis and prognosis of breast cancer patients
08/05/2004WO2004065544A2 Cell suspension rotating fluidic pump
08/05/2004WO2004065542A2 MAT2As AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
08/05/2004WO2004065541A2 Method and apparatus for treating bodily tissues with medicinal substance
08/05/2004WO2004005465A3 Compositions and methods for the detection of human t cell receptor variable family gene expression
08/05/2004WO2003104392A3 Improved reagents and methods for producing parvoviruses
08/05/2004US20040152883 Tocopherol associated protein and uses thereof
08/05/2004US20040152880 Compositions and methods for the reversible capture of biomolecules
08/05/2004US20040152174 Genetically modified eschrichia strain which is capable of biocoversion a single cacrbon source into 1, 3 propanediol using fermentation; bioreactors
08/05/2004US20040152139 for diagnosing/treating prostate cancer by administering immunoconjugates; gene expression inhibition; genetic engineering
08/05/2004US20040152086 Compositions and methods for detecting a sequence mutation in the cinnamyl alcohol dehydragenase gene associated with altered lignification in loblolly pine
08/05/2004US20040151775 Membrane active polymers
08/05/2004CA2829477A1 Gene expression markers for breast cancer prognosis
08/05/2004CA2829476A1 Gene expression markers for breast cancer prognosis
08/05/2004CA2829472A1 Gene expression markers for breast cancer prognosis
08/05/2004CA2513642A1 Diagnosis and prognosis of breast cancer patients
08/05/2004CA2513626A1 Nucleic acid amplification using non-standard bases
08/05/2004CA2513418A1 Microparticles comprising polynucleotide adsorbed on the surface of or entrapped within the microparticles
08/05/2004CA2513308A1 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods
08/05/2004CA2513117A1 Gene expression markers for breast cancer prognosis
08/04/2004EP1442292A2 Integrated system and method for analysis of genomic sequence data
08/04/2004EP1441591A2 Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response
07/2004
07/29/2004WO2004063349A2 Lysozyme transgenic ungulates
07/29/2004WO2004063346A2 Lysozyme transgenic ungulates
07/29/2004WO2004063338A2 Methos for analyzing global regulation of coding and non-coding rna transcripts involving low molecular weight rnas
07/29/2004WO2004063325A2 Method and cloning vector for preparing multiple-gene diagnostic probes for the assessment of multiple markers for breast cancer prognosis
07/29/2004WO2004063323A2 Aflp-based method for integrating physical and genetic maps
07/29/2004WO2004011626A3 Assays and methods based on microcompetition with a foreign polynucleotide
07/29/2004WO2003083065A3 Improved methods for achieving expression from alphavirus vectors
07/29/2004US20040148648 for improved methods of in vitro/vivo re-cloning to improve transgene expression and expression levels in transgenic animals and production of healthier transgenic cells and/or animal models
07/29/2004US20040147470 Nuclease resistance; for therapy and prophylaxis of disease
07/29/2004US20040146907 Methods and compositions for detecting dysplasia
07/29/2004US20040146902 oligomer complementary to and capable of hybridizing to a selected target nucleic acid and at least one protein comprising at least a portion of an RNA-induced silencing complex
07/29/2004US20040146870 Correlating phenotypic characteristic/polymorphisms with position on genetic physical map using haplotype genomes
07/28/2004EP1440411A2 Method of encoding characteristics of a biological sample
07/28/2004CN1159584C Method and medicine box of testing anti-hepatitis C virus antibody
07/22/2004WO2004061085A2 Methods and apparatus for pathogen detection and analysis
07/22/2004WO2004061084A2 Modulation of protein functionalities
07/22/2004WO2004061077A2 Increasing gamete production with a gene switch
07/22/2004WO2004061076A2 Method and apparatus for determining gene expression levels
07/22/2004WO2004033629A3 Reverse transcription on microarrays
07/22/2004WO2003083046A3 Novel proteins and nucleic acids encoding same
07/22/2004US20040142407 Assay for detecting inhibitors of the enzyme mueloperokidase
07/22/2004US20040142362 Inferring gene regulatory networks from time-ordered gene expression data using differential equations
07/22/2004US20040142351 Associative analysis of gene expression array data
07/22/2004US20040142344 Methods and compositions for detection and analysis of polynucleotides using light harvesting multichromophores
07/22/2004US20040142328 Method and cloning vector for preparing multiple-gene diagnostic probes for the assessment of multiple markers for breast cancer prognosis
07/22/2004CA2512071A1 Methods and apparatus for pathogen detection and analysis
07/22/2004CA2511873A1 Modulation of protein functionalities
07/21/2004EP1438418A2 Stem cells of the islets of langerhans and their use in treating diabetes mellitus
07/20/2004US6764687 Live attenuated bacteria for use in a vaccine
07/15/2004WO2003100033A3 ANTI-αvβ6 ANTIBODIES
07/15/2004WO2003070883A3 Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules.
07/15/2004US20040139500 Plastid division and related genes and proteins, and methods of use
07/15/2004US20040139488 Compositions and methods for enhancing disease resistance in fish
07/15/2004US20040139487 Transgenic animal and uses thereof
07/15/2004US20040137429 Of given nucleotide sequence; Complexed with a toxin moiety; Use in treating human immunodeficiency virus (HIV)
07/15/2004US20040137092 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from Uncaria tomentosa and related plants
07/14/2004EP1436611A2 Biological discovery using gene regulatory networks generated from multiple-disruption expression libraries
07/14/2004EP0824588B1 Il-6 activity inhibitor
07/08/2004WO2004057017A2 Detection of small nucleic acids
07/08/2004WO2004044150A3 Systems for gene targeting and producing stable genomic transgen e insertions
07/08/2004WO2004035744A3 Methods for purifying radiolabelled compounds
07/08/2004WO2004027021A3 Device and methods for isolating target cells
07/08/2004WO2004015081A3 Methods for treating circadian rhythm phase disturbances
07/08/2004WO2004014301A3 PSMCs AS MODIFIERS OF THE RB PATHWAY AND METHODS OF USE
07/08/2004US20040132672 Method for inhibiting cancer cells
07/08/2004US20040132660 PRO256 polypeptide; wound healing and anticarcinogenic agents; cardiovascular disorders, atherosclerosis, and cardiac hypertrophy treatment
07/08/2004US20040132181 Trans-splicing mediated photodynamic therapy
07/08/2004US20040132050 Strategies for gene expression analysis
07/08/2004US20040132048 Characterizing methylation pattern of a cell, tissue or organism via providing uniform population of randomly cleaved or sheared DNA comprised methylated and unmethylated nucleotides, separate sequences on methyl binding column and quantify
07/08/2004US20040132047 Methods for detection of genetic alterations associated with cancer
07/08/2004US20040131658 Identification of diet-regulated disease-associated genes
07/08/2004US20040131601 Injection of bone marrow-derived cells and medium for angiogenesis
07/08/2004CA2510381A1 Detection of small nucleic acids
07/07/2004EP1434788A2 Proteins associated with cell growth, differentiation, and death
07/01/2004WO2004018644A3 HETEROGENEOUS FOLDAMERS CONTAINING α, β, AND/OR Ϝ-AMINO ACIDS
07/01/2004US20040128082 Quantifying nucleic acid concentration of messenger RNA species using affinity value and hybridization intensity value; microarrays and transcriptional analysis
07/01/2004US20040128080 Clustering biological data using mutual information
07/01/2004US20040126771 PRNA chimera
06/2004
06/29/2004US6756523 Adenovirus vectors for the transfer of foreign genes into cells of the central nervous system particularly in brain
06/24/2004WO2004053105A2 Direct snp detection with unamplified dna
1 ... 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 ... 100